1. Home
  2. AMCR vs PODD Comparison

AMCR vs PODD Comparison

Compare AMCR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amcor plc

AMCR

Amcor plc

HOLD

Current Price

$43.28

Market Cap

20.4B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$237.83

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCR
PODD
Founded
1926
2000
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4B
17.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
AMCR
PODD
Price
$43.28
$237.83
Analyst Decision
Buy
Strong Buy
Analyst Count
8
20
Target Price
$53.67
$358.00
AVG Volume (30 Days)
4.7M
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.48
Revenue
N/A
$2,708,100,000.00
Revenue This Year
$56.27
$24.33
Revenue Next Year
$1.47
$19.33
P/E Ratio
$33.69
$69.44
Revenue Growth
N/A
30.73
52 Week Low
$7.67
$230.08
52 Week High
$50.94
$354.88

Technical Indicators

Market Signals
Indicator
AMCR
PODD
Relative Strength Index (RSI) 45.67 36.55
Support Level $8.45 N/A
Resistance Level $45.49 $299.75
Average True Range (ATR) 1.09 8.38
MACD -1.75 0.50
Stochastic Oscillator 8.67 10.26

Price Performance

Historical Comparison
AMCR
PODD

About AMCR Amcor plc

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: